
Liquidity, historical trends, and peer comparisons.
According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.91. This represents a change of -12.04% compared to the average of 16.94 of the last 4 quarters.
The mean historical Current Ratio of Tyra Biosciences, Inc. over the last ten years is 27.11. The current 14.91 Current Ratio has changed -45.01% with respect to the historical average. Over the past ten years (40 quarters), TYRA's Current Ratio was at its highest in in the March 2021 quarter at 91.74. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
27.11
Median
14.67
Minimum
0.02
Maximum
84.09
Discovering the peaks and valleys of Tyra Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 33.28%
Maximum Annual Current Ratio = 84.09
Minimum Annual Increase = -69.41%
Minimum Annual Current Ratio = 0.02
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 14.67 | -38.38% |
| 2024 | 23.81 | 72.46% |
| 2023 | 13.80 | -69.41% |
| 2022 | 45.13 | -46.33% |
| 2021 | 84.09 | 922.40% |
| 2020 | 8.22 | 33.28% |
The current Current Ratio of Tyra Biosciences, Inc. (TYRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.43
5-year avg
36.30
10-year avg
27.11
Tyra Biosciences, Inc.’s Current Ratio is greater than Verastem, Inc. (2.25), greater than ORIC Pharmaceuticals, Inc. (13.19), greater than ArriVent BioPharma, Inc. (14.16), greater than Bicara Therapeutics Inc. Common Stock (11.59), less than Janux Therapeutics, Inc. (16.35), greater than MacroGenics, Inc. (2.96), greater than Cullinan Therapeutics, Inc. (8.42), greater than Nuvation Bio Inc. (8.37), greater than Kura Oncology, Inc. (4.73), greater than Foghorn Therapeutics Inc. (3.36),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.25 | $878.01M | |
| 13.19 | $958.79M | |
| 14.16 | $682.91M | |
| 11.59 | $552.54M | |
| 16.35 | $1.08B | |
| 2.96 | $157.02M | |
| 8.42 | $912.65M | |
| 8.37 | $1.64B | |
| 4.73 | $882.49M | |
| 3.36 | $121.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tyra Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tyra Biosciences, Inc. (TYRA)?
What is the highest Current Ratio for Tyra Biosciences, Inc. (TYRA)?
What is the 3-year average Current Ratio for Tyra Biosciences, Inc. (TYRA)?
What is the 5-year average Current Ratio for Tyra Biosciences, Inc. (TYRA)?
How does the current Current Ratio for Tyra Biosciences, Inc. (TYRA) compare to its historical average?